“Gut Microbiota Metabolites As A New Therapeutic Target In Patients With Coronary Artery Disease And Atrial Fibrillation”. Journal of Pharmaceutical Negative Results (January 1, 2023): 1221–1227. Accessed June 9, 2026. https://mail.pnrjournal.com/index.php/home/article/view/7523.